They found that TRIM16 deficiency significantly worsened myocardial cell hypertrophy, while TRIM16 overexpression had a beneficial effect, reducing myocardial hypertrophy and remodelling through activation of the downstream Nrf‐2 pathway.34 Here, TRIM16 is linked to hypertrophy.